Myrobalan News

News Feb 23, 2026

Myrobalan Therapeutics Presents Collaborative Research Featuring GPR17 Antagonist at ACTRIMS 2026

Press Release Mar 13, 2025

Myrobalan Therapeutics Awarded a Grant from the National Multiple Sclerosis Society to Advance Development of MRO-002 in Multiple Sclerosis

Press Release Oct 31, 2024

Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer

Press Release Oct 16, 2024

Myrobalan Therapeutics Strengthens Board of Directors with Appointment of Emma Reeve

Press Release Sep 18, 2024

Myrobalan Presents GPR17 Antagonist Preclinical Data at ECTRIMS 2024

Press Release Jul 29, 2024

Myrobalan Therapeutics Names Grant Bogle to Board of Directors

News May 2, 2024

Co-Founder, Professor Guoping Feng (MIT/Broad) Inducted into the National Academy of Sciences

Press Release Feb 7, 2024

Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program

Press Release Jan 10, 2024

Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential

1
2